Health Care & Life Sciences » Biotechnology | Santhera Pharmaceuticals Holding AG

Santhera Pharmaceuticals Holding AG | Balance Sheet

Fiscal year is January-December. All values CHF Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
5,044.00
17,435.00
76,859.00
49,815.00
61,206.00
24,971
Total Accounts Receivable
42.00
1,049.00
2,177.00
4,276.00
5,402.00
7,861
Inventories
-
-
3,441.00
7,676.00
10,147.00
9,282
Other Current Assets
301.00
47.00
1,467.00
583.00
853.00
969
Total Current Assets
5,387.00
18,531.00
83,944.00
62,350.00
77,608.00
43,083
Net Property, Plant & Equipment
39.00
132.00
398.00
517.00
2,157.00
2,269
Total Investments and Advances
-
85.00
190.00
270.00
5,213.00
2,190
Intangible Assets
4,225.00
4,274.00
29,559.00
26,549.00
23,560.00
61,467
Other Assets
85.00
-
-
-
-
-
Total Assets
9,736.00
23,022.00
117,152.00
90,792.00
109,780.00
110,294
Accounts Payable
597.00
1,654.00
3,290.00
3,574.00
3,585.00
Income Tax Payable
-
-
-
-
432.00
Other Current Liabilities
1,036.00
1,373.00
3,658.00
6,684.00
9,229.00
Total Current Liabilities
1,633.00
3,027.00
6,948.00
10,258.00
13,246.00
Long-Term Debt
-
-
-
-
53,111.00
Provision for Risks & Charges
997.00
2,680.00
3,957.00
6,183.00
8,375.00
Deferred Taxes
-
-
3,061.00
1,106.00
1,242.00
Other Liabilities
-
-
-
-
2,792.00
Total Liabilities
2,630.00
5,707.00
10,905.00
16,441.00
77,524.00
Common Equity (Total)
7,106.00
17,315.00
106,247.00
74,351.00
32,256.00
Total Shareholders' Equity
7,106.00
17,315.00
106,247.00
74,351.00
32,256.00
Total Equity
7,106.00
17,315.00
106,247.00
74,351.00
32,256.00
Liabilities & Shareholders' Equity
9,736.00
23,022.00
117,152.00
90,792.00
109,780.00

About Santhera Pharmaceuticals Holding

View Profile
Address
Hohenrainstrasse 24
Pratteln Basel-Landschaft (Basle Country) 4133
Switzerland
Employees -
Website http://www.santhera.com
Updated 07/08/2019
Santhera Pharmaceuticals Holding AG is a pharmaceutical company. It engages in the development, marketing, and commercialization of pharmaceutical products for the treatment of neuro-ophthalmological, neuromuscular, and pulmonary diseases. It offers its products under the Raxone brands.